Yearly Archives: 2024

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges TO NOTE: This is the second of three MSNs covering discontinuations of Novo Nordisk insulin products (NovoRapid® FlexTouch®, Insulatard® Penfill® and all Levemir® presentations). A third MSN will provide clinical [...]

The post Medicine Supply Notification: Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 5 December 2024) has been published and includes articles on: Letters and medicine recalls sent to healthcare professionals in November 2024 To see th...

Today the Government announced that regulations restricting the prescribing and supply of puberty-suppressing hormones – which were due to expire at the end of December –will be made indefinite. The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024 will come into force on 1 January 2025 as the current emergency order expires and [...]

The post Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues will be made indefinite appeared first on Community Pharmacy England.

The Managing Director of Jardines (UK) Ltd and Superintendent Pharmacist of Pearl Chemist Group have been selected as non-CCA multiple observers to the Community Pharmacy England Committee. The establishment of two contributing observer places is an interim measure to ensure pharmacy owners with 10 or more pharmacies are well represented, while the Committee considers more [...]

The post Additional non-CCA multiples appointed to Community Pharmacy England Committee appeared first on Community Pharmacy England.

Update 02/05/25 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Cefalexin 125mg/5ml oral suspension sugar free (SSP077) which was due to expire 02 May 2025 but has been further extended to Friday 1 August 2025. Community Pharmacy England’s in-house Drug Tariff and funding [...]

The post SSP077 for Cefalexin 125mg/5ml oral suspension sugar free further extended appeared first on Community Pharmacy England.